New funds have been invested into the development of new, highly-efficient mucosal vaccines. The vaccines will be drinkable or given as a nasal spray. Researchers wil combine technologies to develop the next generation of effective mucosal vaccines based on immunomodulation and cell-targeted nanoparticles.